AI-supported education for people with migraine
Tests AI-assisted education added to standard teaching for adults with migraine.
Plain-language title generated from the registry record
Registry title: AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
Key facts
- Where
- Lugano, SwitzerlandSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Source: NCT06507150, who can take part
Where in Switzerland
- Ente Ospedaliero Cantonale - Ospedale Regionale di LuganoLugano, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Ente Ospedaliero Cantonale, Bellinzona
- Trial code
- NCT06507150
- Record updated
- 12 March 2026
- Original description
Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.Read full original descriptionShow less
AI-assisted Migraine Education: Efficacy, Safety and Patients' Acceptance
Migraine affects 1 in 7 people globally, significantly impacting quality of life and economic productivity. Despite its prevalence, limited awareness leads to misdiagnosis, inadequate treatment, and stigmatization. AI can enhance migraine management through improved diagnosis, prediction, and personalized education. The primary objective of this study is to determine if adding AI-assisted migraine education to standard education improves patients' understanding of their condition more effectively.
Inclusion: aged between 18 and 65 years at the time of signing the informed consent; Newly diagnosis of migraine, confirmed through the medical chart; The participant must be capable of giving signed informed consent; Access to a laptop, computer, smartphone, or tablet.
Exclusion: Patients with cognitive impairment and/or unable to use or access the AI-powered learning platform developed in this study; Insufficient knowledge of the protocol language (italian); Vulnerable participants (e.g. minors, participants incapable of judgment or participants under tutelage).